ifetroban 相關文章
-
2023年5月24日 — Cumberland Pharmaceuticals has announced plans to launch the Phase II FIGHTING FIBROSIS trial of oral ife...
-
The sodium salt form of ifetroban, an orally bioavailable thromboxane (TxA2) and prostaglandin H2 (PGH2) (TP) receptor a...
-
Ifetroban is a potent and selective thromboxane receptor antagonist. It has been studied in animal models for the treatm...
-
Ifetroban shows antiplatelet activity, and inhibits tumor cell migration without affecting cell proliferation. Ifetroban...
-
Ifetroban is an orally bioavailable thromboxane (TxA2) and prostaglandin H2 (PGH2) (TP) receptor antagonist, with anti-t...
-
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) ... Brief Summary: Ifetroban prevents and treats lun...
-
Exclusion criteria: · Age 7-9 years - 0.2-0.6 mg/dL · Age 10-11 years - 0.3-0.7 mg/dL · Age 12-13 years - 0.4-0.8 mg/dL ...
-
由 TM Laidlaw 著作 · 2023 · 被引用 3 次 — Ifetroban reduces coronary artery dysfunction in a mouse model of Duchenne musc...
ifetroban 參考影音
繼續努力蒐集當中...